(Q37863779)

24 August 2017

1 reference

title

The renin system in high blood pressure, from disbelief to reality: converting-enzyme blockade for analysis and treatment (English)

1 reference

24 August 2017

The renin system in high blood pressure, from disbelief to reality: Converting-enzyme blockade for analysis and treatment (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Cardiology and cardiovascular medicine

13 January 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

13 January 2023

author name string

J. H. Laragh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214815

13 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=214815

13 January 2023

publication date

1 November 1978

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:003306207890021X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

https://api.elsevier.com/content/article/PII:003306207890021X?httpAccept=text/plain

13 January 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Progress in Cardiovascular Diseases

13 January 2023

published in

1 reference

24 August 2017

volume

21

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

159-166

1 reference

24 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

13 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Aldosterone secretion and primary and malignant hypertension

13 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

13 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension

13 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

13 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

13 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability

13 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

13 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Essential hypertension: renin and aldosterone, heart attack and stroke.

13 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Renin as a predictor of hypertensive complications

13 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

13 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

13 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

13 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

13 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

13 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

The biochemistry of the renin-angiotensin system and its role in hypertension

13 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme

13 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

13 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90021-X

13 January 2023

Identifiers

1 reference

24 August 2017

1 reference